Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Director departure
|
|
CALYPTE BIOMEDICAL CORP (CBMC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2014 |
8-K
| Quarterly results |
| 06/24/2014 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/18/2014 |
8-K
| Material Modifications to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statemen... |
| 02/28/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 01/15/2014 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 02/11/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/03/2013 |
8-K
| Form 8-K - Current report |
| 01/02/2013 |
4
| Al Yousefi Tareq (Director) has filed a Form 4 on CALYPTE BIOMEDICAL CORP|
Txns:
| Granted 500,000 options to buy
@ $0.03, valued at
$15k
|
|
| 01/02/2013 |
4
| Edilashvili Kartlos (CFO and Secretary) has filed a Form 4 on CALYPTE BIOMEDICAL CORP|
Txns:
| Granted 2,000,000 options to buy
@ $0.03, valued at
$60k
|
|
| 01/02/2013 |
4
| KARAS ADEL (President and CEO) has filed a Form 4 on CALYPTE BIOMEDICAL CORP|
Txns:
| Granted 5,000,000 options to buy
@ $0.03, valued at
$150k
|
|
| 12/31/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
| 11/15/2012 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 08/14/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
| 05/15/2012 |
10-Q
| Quarterly Report for the period ended March 31, 2012 |
| 04/30/2012 |
8-K
| Form 8-K - Current report |
| 03/22/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
| 02/14/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/27/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2011 |
| 11/30/2011 |
10-Q/A
| Quarterly Report for the period ended June 30, 2011 [amend] |
| 11/29/2011 |
10-Q
| Quarterly Report for the period ended June 30, 2011 |
| 11/15/2011 |
10-K/A
| Annual Report for the period ended December 31, 2010 [amend] |
| 11/15/2011 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 10/14/2011 |
8-K
| Form 8-K - Current report |
| 09/15/2011 |
10-Q
| Quarterly Report for the period ended March 31, 2011 |
| 08/16/2011 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 05/27/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 05/17/2011 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 04/01/2011 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| 03/02/2011 |
GN
| Calypte Biomedical Announces Successful Conclusion of Internal Trials |
| 02/14/2011 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/28/2011 |
10-Q
| Quarterly Report for the period ended September 30, 2010 |
| 11/19/2010 |
10-Q/A
| Quarterly Report for the period ended June 30, 2010 [amend] |
| 10/29/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
|
|
|